THRD

10.84

0.37% -0.04

Dopo l'orario di chiusura: 10.84

Third Harmonic Bio Inc (THRD)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione

Precedente Chiudi:

$10.88

Aprire:

$10.58

Volume 24 ore:

389.17K

Relative Volume:

1.98

Capitalizzazione di mercato:

$488.43M

Reddito:

Utile/perdita netta:

$-32.74M

Rapporto P/E:

-6.8966

EPS:

-1.5718

Flusso di cassa netto:

$-24.89M

1 W Prestazione:

-3.73%

1M Prestazione:

-6.71%

6M Prestazione:

-12.16%

1 anno Prestazione:

+1.69%

Intervallo 1D:

$10.40

$11.19

Intervallo di 1 settimana:

$10.40

$11.88

Portata 52W:

$8.075

$16.94

Third Harmonic Bio Inc Stock (THRD) Company Profile

Nome

Third Harmonic Bio Inc

Settore

Healthcare (1176)

Industria

Biotechnology (673)

Telefono

(209) 727-2457

Indirizzo

1700 MONTGOMERY STREET, SAN FRANCISCO

Dipendente

Cinguettio

Prossima data di guadagno

Ultimi documenti SEC

THRD's Discussions on Twitter

Confronta THRD con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
THRD Third Harmonic Bio Inc	10.84	488.43M	0	-32.74M	-24.89M	-0.82
VRTX Vertex Pharmaceuticals Inc	397.27	102.31B	10.63B	-479.80M	-1.35B	-1.99
REGN Regeneron Pharmaceuticals Inc	701.85	77.13B	13.85B	4.65B	3.32B	40.41
ARGX Argen X Se Adr	623.82	37.30B	1.86B	-40.29M	-1.28B	-0.85
ALNY Alnylam Pharmaceuticals Inc	245.44	31.66B	2.09B	-332.26M	16.06M	-2.62
BNTX Biontech Se Adr	113.08	27.11B	3.30B	-501.07M	1.03B	-2.1146

Third Harmonic Bio Inc Stock (THRD) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2024-08-09	Aggiornamento	Morgan Stanley	Equal-Weight → Overweight
2024-06-18	Iniziato	Stifel	Buy
2024-06-07	Iniziato	Raymond James	Outperform
2022-12-16	Downgrade	Jefferies	Buy → Hold
2022-12-15	Downgrade	Morgan Stanley	Overweight → Equal-Weight
2022-10-10	Iniziato	Cowen	Outperform
2022-10-10	Iniziato	Jefferies	Buy
2022-10-10	Iniziato	Morgan Stanley	Overweight

Mostra tutto

Third Harmonic Bio Inc Borsa (THRD) Ultime notizie

Dec 17, 2024

Long Term Trading Analysis for (THRD) - Stock Traders Daily

Dec 17, 2024

Third Harmonic Bio's SWOT analysis: oral KIT inhibitor stock shows promise - Investing.com Australia

Dec 17, 2024

Dec 10, 2024

Third Harmonic Bio's SWOT analysis: stock outlook brightens on clinical progress - Investing.com India

Dec 10, 2024

Third Harmonic Bio's SWOT analysis: stock outlook brightens on clinical progress By Investing.com - Investing.com South Africa

Dec 10, 2024

Dec 05, 2024

Atlas Venture Announces $450 Million Fund XIV - Yahoo Finance

Dec 05, 2024

Nov 26, 2024

How the (THRD) price action is used to our Advantage - Stock Traders Daily

Nov 26, 2024

Nov 25, 2024

Third Harmonic Bio to Participate in the 7th Annual Evercore HealthCONx Conference - Marketscreener.com

Nov 25, 2024

Third Harmonic Bio to Present at Evercore HealthCONx Conference in December | THRD Stock News - StockTitan

Nov 25, 2024

Nov 20, 2024

Wall Street Analysts Believe Third Harmonic Bio, Inc. (THRD) Could Rally 26.67%: Here's is How to Trade - MSN

Nov 20, 2024

Nov 15, 2024

(THRD) Technical Pivots with Risk Controls - Stock Traders Daily

Nov 15, 2024

RA Capital Management Reduces Stake in Third Harmonic Bio Inc - GuruFocus.com

Nov 15, 2024

Nov 14, 2024

Significant Stake Increase by T. Rowe Price in Third Harmonic Bi - GuruFocus.com

Nov 14, 2024

Nov 11, 2024

Vertiv Rises 13% in a Month: Time for Investors to Buy the Stock? - MSN

Nov 11, 2024

Shiba Inu (SHIB) Price Rises 53% but Hits Rejection at Key Ascending Resistance Level - MSN

Nov 11, 2024

Nov 08, 2024

Third Harmonic Bio Reports Q3 2024 Financial Results - TipRanks

Nov 08, 2024

Nov 07, 2024